Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. - Wikidata - awgldk - TriplyDB

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.

http://www.wikidata.org/entity/Q41703759

about

Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma Recent Molecular Advances in Our Understanding of Glioma Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.Management of low-grade glioma.Low-grade gliomas in older patients: a retrospective analysis of prognostic factors.Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.Advances in the Surgical Management of Low-Grade Glioma The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Detecting tumor progression in glioma: Current standards and new techniques.Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Postoperative radiotherapy of astrocytomas.Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.Controversies in the therapy of low-grade glioma: when and how to treat.Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424 Stereotactic radiosurgery in the management of intracranial gliomas.IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging Role of radiotherapy in the treatment of gliomas.Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice Proliferation and aneusomy predict survival of young patients with astrocytoma grade II.The Value of Pre- and Intraoperative Adjuncts on the Extent of Resection of Hemispheric Low-Grade Gliomas: A Retrospective Analysis.Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.Low-grade gliomas: management issues.Incidence of and survival from oligodendroglioma in Denmark, 1943-2002 Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article Current concepts in the evaluation and management of WHO grade II gliomas.Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.Pilomyxoid astrocytoma of the cervical spinal cord in a child with rapid progression into glioblastoma: case report and literature review.The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Outcomes in Reoperated Low-Grade Gliomas.Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas.Quantitative MR perfusion parameters related to survival time in high-grade gliomas.F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study.Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas.Surgical oncology for gliomas: the state of the art.Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.

P2860

Q21261321-0E467ECB-8282-43D6-A9DA-B0D96273FE39 Q26798442-8420D8C7-5064-4209-87C6-EEDB59020964 Q30425164-CB7357AB-F5BE-4A40-9692-057F10F2AE54 Q30436353-10953B50-DABC-4587-A30D-5E0B07BECC91 Q30446709-2B2C8A99-F12A-49E0-9528-FA70959F5D36 Q30680698-251C0336-A246-4A37-A879-F849D8639A2B Q30967374-FC485EAD-FCB2-4C87-904A-7E2890C03183 Q31016200-374DDB52-90A1-4951-9751-A1B149EB161C Q31016208-5B506C12-C27E-43A4-9D95-10A0EF5D2E7A Q31132701-F8182857-2117-45AC-9072-CBE5EF58B9A3 Q33408998-46FA20AE-3784-41A0-B24F-AF8869C0582A Q33894486-7A167962-5823-4BE6-A289-D4F928C401AC Q34210447-29EC823F-0C1B-4430-9A75-D4226BD5E821 Q34722450-57F59232-BE00-4EB0-B8F9-50CC597F134C Q34969223-D5C65839-AA3E-4B38-83A6-BDB3A0D131A0 Q35085561-86DA8ABF-71C4-4343-84CF-1767C420ADC6 Q35101595-91F9D719-049E-46D5-8200-1ACBFD407CAD Q35204658-94C96C37-A8BA-4401-A2DC-4F84D7CD3092 Q35762234-BE5239DF-2D5B-4720-888F-FD071C48EC3A Q36307807-7C130143-D58E-4EA4-93DE-ABFEBBF376FF Q36326878-2212BF9E-1E9E-48E0-A988-2AD8773BDD92 Q36670841-19020D62-8D87-4C0F-994E-35A0A89CD3AD Q36812026-1ACA66D3-5E9B-47A8-A24C-C4544CEC65A1 Q36915106-308F8B24-406B-4C6C-A9B4-0730E8D14F7A Q37030794-CBF702A4-677B-47D2-A332-6161A24ADA79 Q37284267-302E87D9-F4D2-4705-9A38-C9B6334B7DC4 Q37284308-59A0C3DB-82E7-4436-AD33-A411AACDA284 Q37344962-566AA7D4-6D94-4A1A-8277-8D329A9D0D8A Q37424274-48B221DE-ED87-47A8-8F42-83EBB339F0E3 Q37439472-0862352B-CD78-4A26-9C1D-4AA83E1DC3D3 Q37462007-8BAF35F3-01CF-4FD1-8144-2E557FF87717 Q37749661-D4F1477F-5E47-472C-9EC8-69036F3DD141 Q38623617-03CA5334-4E9D-41C9-9E98-109D5A991847 Q41104618-3D62EBD2-074D-446B-AF7A-D0FA83E13513 Q43824323-719154DC-3A9F-4B52-A0AF-1D1A6A6DDAAE Q43860815-923E2312-C8A3-49A1-90D2-A94BB7567F5A Q45828622-FAC3B9D9-8279-4739-B424-F39BF17399B3 Q45934089-B0327CC6-4DEB-4DE4-8A3A-C0203E5A1DFB Q46138607-22A08C2D-479C-41F9-9357-8A7EDEADB653 Q47368483-094FF6C4-8879-4BDF-9865-714205580DCB

P2860

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.

http://www.wikidata.org/entity/Q41703759

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Pretreatment factors predict o ...... cursive partitioning analysis.

@en

type

label

Pretreatment factors predict o ...... cursive partitioning analysis.

@en

prefLabel

Pretreatment factors predict o ...... cursive partitioning analysis.

@en

P1433

Q41703759-B64A23E1-B662-4FB3-A549-305F75E542B0

P1476

Q41703759-951BEC78-9010-4419-A70C-07BD87C3D711

P2093

Q41703759-1FF76925-DCB2-4FA3-AEB5-B0921CFCC4C0

Q41703759-363752B3-B59B-45CC-AD6C-A5B9D514A977

Q41703759-411B7D25-1F15-49DC-AE55-FC2D2DE100E0

Q41703759-4F00E527-968F-4DE8-BAAD-96FD26DE1C9C

Q41703759-6A9A314A-C919-4C90-AE2F-ACCEB07990E8

Q41703759-827C3FD7-54DC-4144-B94E-B90DBB0AFB34

Q41703759-85F51039-7CEE-4F0C-84A2-F31B85DBE2F6

Q41703759-A3FE8D74-EE0A-4CF8-A19E-86C2310A4F49

Q41703759-AF90A61E-6809-4704-B502-0C09A604CF64

Q41703759-B64AFA20-3FE9-46D6-BB36-AD677B958042

P304

Q41703759-0EAB870D-A55F-4B2F-B986-594DC615720F

P31

Q41703759-344E64FF-B60E-48BB-BBDF-B825E2546D8B

P356

Q41703759-468996DD-154E-41BC-9F34-6F98CB495854

P407

Q41703759-E50AFA17-9B1D-4357-99F3-AAC7829C6392

P433

Q41703759-B880A0E9-FF44-4580-BD83-571F83C724B5

P478

Q41703759-E3E603C1-BB98-4DEA-8C8A-8582DCD53170

P577

Q41703759-78309FEF-D7F3-4348-88E6-81E40106B443

P698

Q41703759-6D90043A-9353-4083-8070-A4CD47D8BB40

P356

S0360-3016(99)00284-9

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Pretreatment factors predict o ...... cursive partitioning analysis.

@en

P2093

Bauman G

http://www.w3.org/2001/XMLSchema#string

Cairncross JG

http://www.w3.org/2001/XMLSchema#string

Fisher B

http://www.w3.org/2001/XMLSchema#string

Larson D

http://www.w3.org/2001/XMLSchema#string

Leighton C

http://www.w3.org/2001/XMLSchema#string

Lote K

http://www.w3.org/2001/XMLSchema#string

MacDonald D

http://www.w3.org/2001/XMLSchema#string

Stalpers L

http://www.w3.org/2001/XMLSchema#string

Stitt L

http://www.w3.org/2001/XMLSchema#string

Wara W

http://www.w3.org/2001/XMLSchema#string

P304

923-929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0360-3016(99)00284-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10571199

http://www.w3.org/2001/XMLSchema#string